EMEA-000727-PIP01-09-M03

Key facts

Invented name
Bosulif
Active substance
Bosutinib
Therapeutic area
Oncology
Decision number
P/0282/2019
PIP number
EMEA-000727-PIP01-09-M03
Pharmaceutical form(s)
  • Capsule, hard
  • Film-coated tablet
Condition(s) / indication(s)
Treatment of chronic myeloid leukaemia (CML)
Route(s) of administration
Oral use
Contact for public enquiries
Pfizer Europe MA EEIG

Tel. +44 1304 6466 07
E-mail: PIP_enquiries@pfizer.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating